Abstract
Background: In 2009, approximately 40 million people were 65 years or older. The majority of people over the age of 65 have at least one chronic medical condition. In 2002-2003, the following medical conditions were common among older adults: hypertension (51%), arthritis (48%), heart disease (31%), cancer of any type (21%), and diabetes (16%). The cost of diabetes care, both direct and indirect, was $245 billion in 2012. Fifty-nine percent of the direct medical cost was for the population aged 65 and over.
Methods: A literature review was conducted with a review of mostly peer-reviewed publications from 1987 – 2016 in the preparation of this manuscript. Results: Management goals include control and minimization of hypo- and hyperglycemia and their symptoms, evaluation and treatment of associated risks for atherosclerotic and micro-vascular disease; evaluation and treatment of related complications; support for diabetes self-management and education; maintenance or improvement of the patient's general health status. Conclusion: Providers, patients, caregivers and family members should be vigilant to recognize and manage, micro - and macro-vascular diseases quickly, to prevent increased incidence in morbidity and mortality, as well as medical costs of diabetes care attributed to this age group.Keywords: Diabetes complications, diabetes management, elderly/older adult, hypo- and hyper-glycemia, insulin therapy, lifestyle modification, Type 1/Type 2 diabetes.
Current Diabetes Reviews
Title:Clinical Management of Diabetes Mellitus in the Older Adult Patient
Volume: 13 Issue: 3
Author(s): Nana Yaw Adu-Sarkodie*
Affiliation:
- VA Maryland Health Care System (VAMHCS), Geriatrics and Extended Care (GEC), Home Based Primary Care Program (HBPC), Loch Raven VA Community Living and Rehabilitation Center, 3900 Loch Raven Blvd, Baltimore, Maryland 21218,United States
Keywords: Diabetes complications, diabetes management, elderly/older adult, hypo- and hyper-glycemia, insulin therapy, lifestyle modification, Type 1/Type 2 diabetes.
Abstract: Background: In 2009, approximately 40 million people were 65 years or older. The majority of people over the age of 65 have at least one chronic medical condition. In 2002-2003, the following medical conditions were common among older adults: hypertension (51%), arthritis (48%), heart disease (31%), cancer of any type (21%), and diabetes (16%). The cost of diabetes care, both direct and indirect, was $245 billion in 2012. Fifty-nine percent of the direct medical cost was for the population aged 65 and over.
Methods: A literature review was conducted with a review of mostly peer-reviewed publications from 1987 – 2016 in the preparation of this manuscript. Results: Management goals include control and minimization of hypo- and hyperglycemia and their symptoms, evaluation and treatment of associated risks for atherosclerotic and micro-vascular disease; evaluation and treatment of related complications; support for diabetes self-management and education; maintenance or improvement of the patient's general health status. Conclusion: Providers, patients, caregivers and family members should be vigilant to recognize and manage, micro - and macro-vascular diseases quickly, to prevent increased incidence in morbidity and mortality, as well as medical costs of diabetes care attributed to this age group.Export Options
About this article
Cite this article as:
Adu-Sarkodie Yaw Nana*, Clinical Management of Diabetes Mellitus in the Older Adult Patient, Current Diabetes Reviews 2017; 13(3) . https://dx.doi.org/10.2174/1573399812666161206151706
DOI https://dx.doi.org/10.2174/1573399812666161206151706 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets The Use of Interferons in Respiratory Diseases
Current Respiratory Medicine Reviews High Glucose Enhances Neurotoxicity and Inflammatory Cytokine Secretion by Stimulated Human Astrocytes
Current Alzheimer Research Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism
CNS & Neurological Disorders - Drug Targets Mechanisms of Cardiovascular Changes in an Experimental Model of Syndrome X and Pharmacological Intervention on the Renin-Angiotensin- System
Current Vascular Pharmacology Therapeutic Targets in Inflammatory Disease
Current Medicinal Chemistry The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews Incretin-Based Therapy of Type 2 Diabetes Mellitus
Current Protein & Peptide Science Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Current Protein & Peptide Science Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to Pitavastatin
Current Vascular Pharmacology Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
Current Vascular Pharmacology Stenting Renal Artery Stenosis: What is the Fuss All About?
Reviews on Recent Clinical Trials Coronary Intravascular Ultrasound (IVUS): Contemporary Applications and Bases for the Future
Recent Patents on Medical Imaging Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Ezetimibe Therapy for Dyslipidemia: An Update
Current Pharmaceutical Design Dopamine Administration in Very Low Birth Weight Preterm Infants:Emerging Issues on Endocrine Effects
Current Pediatric Reviews Glucose Lowering Activity of Aqueous Ammodaucus leucotrichus Extract in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets